Merck & Co. has initiated a major cost-cutting program that will save $3 billion by 2027. The multiyear program of optimization, outlined in its Q2 2025 earnings announcement
The Central Drugs Standard Control Organisation (CDSCO) has introduced a QR Code-based appointment booking for stakeholders visiting CDSCO’s headquarters located in the FDA Bhawan at New Delhi
GlaxoSmithKline (GSK) recently revealed that it had allied with Chinese Hengrui Pharma to co-develop up to 12 novel medicines. The collaboration was valued at potentially up to $12 billion and is intended to support GSK’s long-term growth
The Delhi High Court has declined to issue directions to Zydus Lifesciences to disclose the manufacturing process of its breast cancer drug Sigrima, following a plea by Swiss multinational F. Hoffmann-La Roche.
Under the Production Linked Incentive (PLI) Scheme aimed at increasing domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)
The historic India-UK Free Trade Agreement (FTA) signed on Thursday will radically boost bilateral trade, particularly in the pharma and medical devices sector, said industry experts.
.jpeg)
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg (USRLD
Dr Reddy's Laboratories is poised to launch a lower-cost generic version of Novo Nordisk's obesity drug Wegovy (semaglutide) in 87 markets from next year.
In a courtroom defeat for Zydus Lifesciences, the Delhi High Court has stayed the company from marketing its proposed biosimilar of the cancer drug Nivolumab
Some of the latest trends that will steer the market include omnichannel marketing, emotional branding, regulatory first storytelling, and digital asset optimization
, CDSCO.jpg)